The Sanofi Global Health laboratory announced, on July 4, the launch of its Impact brand, which includes 30 drugs at cost price, without any profit, intended for the populations of the poorest countries on the planet, with a priority for Africa.
« Improving access to quality medicines for underserved populations » is the ambition of this French pharmaceutical group.
These reference drugs that will be produced cover several pathologies including diabetes, cardiovascular diseases, tuberculosis, malaria and cancer. The laboratory will use molecules considered essential by the World Health Organization (WHO).
Some 40 low-income countries will benefit from the program. These include, among others, Mozambique, Zambia, Niger and Zimbabwe.
The laboratory expects the first drug deliveries in the coming months, depending on drug registration deadlines. It ensures that the quality of the products will be the same as those of the drugs sold in France.
“We are going to sell our products at the lowest possible price. If we make a margin, every cent of the euro earned will be reinvested in health and education programs in these countries,” Jon Fairest, head of Sanofi Global Health, told AFP.
And to add, « we do not just want to bring drugs to patients, but also to have education programs so that patients understand how to follow these treatments, in countries which have almost no health system ».
Sanofi stresses that the launch of the Impact brand is part of the measures taken since the creation, in 2021, of Sanofi Global Health, the company’s not-for-profit entity whose vocation is to improve the access to care through the distribution of medicines, and to build and strengthen health systems in countries where GDP per capita is among the lowest in the world.
Sanofi Global Health is the first and only global initiative to enable access to such a broad portfolio of medicines, in so many countries and therapeutic areas, while funding local support programs and strengthening local companies committed to an inclusive process.
By OMA Newsletter N° 770 of 06/07/2022
Article published under the direction of Dr. Najib Kettani
The OMA, NGO with an Intercontinental vocation
For the development of cultural exchanges
Valuing human potential
The promotion and consolidation of Africa’s development, and
Inter-African integration
